It’s Official! NOWDx Acquires CELLMIC Reader Technology

SPRINGDALE, ARK. – July 12, 2018 – NOW Diagnostics Inc. announced today that it has acquired the rapid assay reader product lines and related assets of mobile diagnostics company CELLMIC LLC.

NOW Diagnostics acquires #rapid #assay reader technology from #mobile #diagnostics company CELLMIC LLC. #rapidassay #mobilediagnostics @UCLAengineering ‏#science @InnovateUCLA

NOW Diagnostics Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its ADEXUSDx^® product line features a “lab at your fingertip” concept, using a single drop of blood to test for a variety of common conditions, illnesses and diseases, with results in a matter of minutes.

Founded in 2011 as Holomic LLC – a spinoff of Prof. Aydogan Ozcan’s research lab at the UCLA Henry Samueli School of Engineering and Applied Science – CELLMIC, LLC based in Inglewood, California, has developed a series of smartphone-based, rapid assay readers with applications in medical, veterinary, food safety, biodefense and drugs-of-abuse testing. CELLMIC’s products carry the European Union CE Mark and are in use around the world.

Click HERE to read more.

Contacts

NOW Diagnostics Company Contact
Jeff Ellis, VP Sales & Marketing
Phone: 479-966-4540
Email: jeff.ellis@nowdx.com
or
NOW Diagnostics Media Contact
Armada Medical Marketing
Dan Snyders
Phone: 720-231-9990
Email: dan@armadamedical.com
or
Cellmic, LLC Contact
Neven Karlovac, CEO
Phone: 310-897-2096
Email: nkarlovac@cellmic.com

Previous Article Next Article

Check out what is making the news

Find out the latest in diagnostics testing.

First and Only In-Home Test for Syphilis Now Available to Consumers through Major Retailers and Public Health: NOWDiagnostics Launches First To Know® Syphilis Test Across the U.S.

Todd Simpson

With syphilis cases on the rise, NOWDx’s over-the-counter test offers rapid, in-home results in minutes and is now available nationwide in thousands of pharmacies, retail, and drugstore locations and on Amazon SPRINGDALE, Ark. – November 19, 2024 – NOWDiagn...

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

Todd Simpson

As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settingsSPRINGDALE, ARK. – October 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of ...

NOWDiagnostics First To Know® Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use

Todd Simpson

First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announce...